CECCARDI, GIULIA
CECCARDI, GIULIA
Dipartimento di Scienze Cliniche e Sperimentali
An observational study on monoclonal antibodies against calcitonin-gene-related peptide and its receptor
2023-01-01 Schiano di Cola, Francesca; Bolchini, Marco; Ceccardi, Giulia; Caratozzolo, Salvatore; Liberini, Paolo; Rao, Renata; Padovani, Alessandro
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
2022-01-01 Schiano di Cola, Francesca; Caratozzolo, Salvatore; Bolchini, Marco; Ceccardi, Giulia; Cortinovis, Matteo; Liberini, Paolo; Padovani, Alessandro; Rao, Renata
Increased risk of functional neurological disorders following SARS‐CoV‐2 vaccination
2024-01-01 Pilotto, Andrea; Catania, Marcello; Mattioli, Irene; Zoppi, Nicola; Ceccardi, Giulia; Rao, Renata; Gipponi, Stefano; Magoni, Mauro; Gamba, Massimo; Padovani, Alessandro
Migraine Disability and Severity Improvement during Long-Term Treatment with Erenumab
2023-01-01 Bolchini, Marco; Schiano di Cola, Francesca; Ceccardi, Giulia; Caratozzolo, Salvatore; Liberini, Paolo; Rao, Renata; Padovani, Alessandro
Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine
2023-01-01 di Cola, Francesca Schiano; Bolchini, Marco; Caratozzolo, Salvatore; Ceccardi, Giulia; Cortinovis, Matteo; Liberini, Paolo; Rao, Renata; Padovani, Alessandro
Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine
2023-01-01 Ceccardi, Giulia; Schiano di Cola, Francesca; Caratozzolo, Salvatore; Di Pasquale, Michele; Bolchini, Marco; Padovani, Alessandro; Rao, Renata
Photophobia and migraine outcome during treatment with galcanezumab
2022-01-01 Schiano di Cola, Francesca; Ceccardi, Giulia; Bolchini, Marco; Caratozzolo, Salvatore; Liberini, Paolo; Padovani, Alessandro; Rao, Renata
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| An observational study on monoclonal antibodies against calcitonin-gene-related peptide and its receptor | 1-gen-2023 | Schiano di Cola, Francesca; Bolchini, Marco; Ceccardi, Giulia; Caratozzolo, Salvatore; Liberini, Paolo; Rao, Renata; Padovani, Alessandro | |
| CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients | 1-gen-2022 | Schiano di Cola, Francesca; Caratozzolo, Salvatore; Bolchini, Marco; Ceccardi, Giulia; Cortinovis, Matteo; Liberini, Paolo; Padovani, Alessandro; Rao, Renata | |
| Increased risk of functional neurological disorders following SARS‐CoV‐2 vaccination | 1-gen-2024 | Pilotto, Andrea; Catania, Marcello; Mattioli, Irene; Zoppi, Nicola; Ceccardi, Giulia; Rao, Renata; Gipponi, Stefano; Magoni, Mauro; Gamba, Massimo; Padovani, Alessandro | |
| Migraine Disability and Severity Improvement during Long-Term Treatment with Erenumab | 1-gen-2023 | Bolchini, Marco; Schiano di Cola, Francesca; Ceccardi, Giulia; Caratozzolo, Salvatore; Liberini, Paolo; Rao, Renata; Padovani, Alessandro | |
| Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine | 1-gen-2023 | di Cola, Francesca Schiano; Bolchini, Marco; Caratozzolo, Salvatore; Ceccardi, Giulia; Cortinovis, Matteo; Liberini, Paolo; Rao, Renata; Padovani, Alessandro | |
| Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine | 1-gen-2023 | Ceccardi, Giulia; Schiano di Cola, Francesca; Caratozzolo, Salvatore; Di Pasquale, Michele; Bolchini, Marco; Padovani, Alessandro; Rao, Renata | |
| Photophobia and migraine outcome during treatment with galcanezumab | 1-gen-2022 | Schiano di Cola, Francesca; Ceccardi, Giulia; Bolchini, Marco; Caratozzolo, Salvatore; Liberini, Paolo; Padovani, Alessandro; Rao, Renata |